A Twitter-based community of digital healthcare experts have met for the first time in person for an unconference in Berlin

GlaxoSmithKline's (GSK) two-in-one prostate drug Duodart has received approval in Europe

French drugs maker sanofi-aventis has announced that it plans to shift its emphasis to biotechnology and vaccine production

Roche's Xeloda in combination with oxaliplatin has been approved in Europe for the adjuvant treatment of patients with early colon cancer

NICE have issued a preliminary recommendation for sanofi-aventis' Multaq, an anti-arrhythmic drug addressing unmet need in atrial fibrillation

More than 900 packs of a potentially dangerous traditional Chinese medicine are on the UK market despite warnings issued by the MHRA

Business Secretary Lord Mandelson has announced the government's support for developing a network of technology and innovation centres 

Following a majority vote of 393-1, Russia's new pharmaceutical bill is set to become law by September 1

Brussels-based biopharmaceutical company, UCB, has announced Bert De Graeve and Alexandre Van Damme as candidates for the Board

Sanofi-aventis and Bristol-Myers Squibb have received EC approval for their dual antiplatelet combination tablet DuoPlavin/DuoCover

Genzyme has announced that the US Food and Drug Administration will take enforcement action on its plant in Allston, Massachusetts

The European Medicines Agency is marking the 10th anniversary of orphan drug regulation implementation in Europe with a conference and workshops

The Novo Nordisk Foundation has donated DKK885m to the University of Copenhagen to build a new centre for international metabolic research

GSK and Pfizer have signed a deal with the GAVI Alliance to supply vaccines for pneumococcal disease for children in developing countries

Merck has temporarily suspended its Stimuvax clinical programme after a patient developed encephalitis, an acute inflammation of the brain

The US FDA has recommended the suspension of GSK's rotavirus vaccine, Rotarix, after traces of porcine circovirus 1 (PCV1) were detected

As the US Healthcare Reform Bill is given final approval, response from analysts is mixed about the effect its implementation will have on pharma

The first asthma patient has commenced treatment with GlaxoSmithKline's Relovair in a phase III programme

A US state court jury has rejected claims by a Louisiana man that Seroquel caused his diabetes

Israeli Teva has outbid Pfizer and Actavis and entered into a definitive agreement to acquire Ratiopharm for €3.63bn